Margaret Fitzgerald
Compliance Officer at CODEXIS, INC.
Net worth: 466 857 $ as of 2024-03-30
Profile
Margaret Fitzgerald is currently the Secretary, Chief Legal & Compliance Officer at Codexis, Inc. She is also an Associate Attorney at Pillsbury Winthrop Shaw Pittman LLP.
Previously, she worked as an Associate General Counsel at Genentech, Inc., Vice President at ZS Pharma, Inc., Secretary, Chief Compliance Officer & Senior VP at Allakos, Inc., and Associate General Counsel & Privacy Officer at Aimmune Therapeutics, Inc. Fitzgerald received her undergraduate and graduate degrees from Stanford University and her graduate degree from the University of California, Berkeley.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CODEXIS, INC.
0.19% | 2023-12-31 | 133,770 ( 0.19% ) | 466 857 $ | 2024-03-30 |
Margaret Fitzgerald active positions
| Companies | Position | Start |
|---|---|---|
| CODEXIS, INC. | Compliance Officer | 2022-10-31 |
Pillsbury Winthrop Shaw Pittman LLP
 Pillsbury Winthrop Shaw Pittman LLP Miscellaneous Commercial ServicesCommercial Services Pillsbury Winthrop Shaw Pittman LLP provides legal services. It offers services in education, aviation, communications, consumer and retails, corporate and securities, hospital and intellectual property. The company was founded in 1868 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Former positions of Margaret Fitzgerald
| Companies | Position | End |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
| AIMMUNE THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| ZS PHARMA INC | Corporate Officer/Principal | - |
| ALLAKOS INC. | Compliance Officer | - |
Training of Margaret Fitzgerald
| Stanford University | Graduate Degree |
| University of California, Berkeley | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CODEXIS, INC. | Process Industries |
| ALLAKOS INC. | Health Technology |
| Private companies | 4 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
ZS Pharma, Inc.
 ZS Pharma, Inc. Pharmaceuticals: MajorHealth Technology ZS Pharma, Inc. engages in the development of development and commercialization of non-absorbed drugs to treat renal, cardiovascular, liver and metabolic diseases. It develops treatment of hyperkalemia. It also focuses on clinical development, novel technology, and clinical trials. The company was founded by Alvaro F. Guillem and Donald Jeffrey Keyser on February 5, 2008 and is headquartered in San Mateo, CA. | Health Technology |
Pillsbury Winthrop Shaw Pittman LLP
Pillsbury Winthrop Shaw Pittman LLP Miscellaneous Commercial ServicesCommercial Services Pillsbury Winthrop Shaw Pittman LLP provides legal services. It offers services in education, aviation, communications, consumer and retails, corporate and securities, hospital and intellectual property. The company was founded in 1868 and is headquartered in New York, NY. | Commercial Services |
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
- Stock Market
- Insiders
- Margaret Fitzgerald
